ES2094093B1 - Formulaciones farmaceuticas liquidas microbiologicamente estables para un carbonato basico de aluminio y magnesio. - Google Patents
Formulaciones farmaceuticas liquidas microbiologicamente estables para un carbonato basico de aluminio y magnesio.Info
- Publication number
- ES2094093B1 ES2094093B1 ES9401999A ES9401999A ES2094093B1 ES 2094093 B1 ES2094093 B1 ES 2094093B1 ES 9401999 A ES9401999 A ES 9401999A ES 9401999 A ES9401999 A ES 9401999A ES 2094093 B1 ES2094093 B1 ES 2094093B1
- Authority
- ES
- Spain
- Prior art keywords
- magnesium
- aluminum
- basic carbonate
- liquid formulations
- pharmaceutical liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 title abstract 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 title abstract 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 title abstract 3
- 229910052782 aluminium Inorganic materials 0.000 title abstract 3
- 229910052749 magnesium Inorganic materials 0.000 title abstract 3
- 239000011777 magnesium Substances 0.000 title abstract 3
- 239000012669 liquid formulation Substances 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- MTEOMEWVDVPTNN-UHFFFAOYSA-E almagate Chemical compound O.O.[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Mg+2].[Mg+2].[Mg+2].[Al+3].[O-]C([O-])=O MTEOMEWVDVPTNN-UHFFFAOYSA-E 0.000 abstract 1
- 230000000845 anti-microbial effect Effects 0.000 abstract 1
- 239000002131 composite material Substances 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
FORMULACIONES FARMACEUTICAS LIQUIDAS MICROBIOLOGICAMENTE ESTABLES DE CARBONATO BASICO DE ALUMINIO Y MAGNESIO. LAS FORMULACIONES TIENEN COMO COMPONENTE PRINCIPAL EL CARBONATO BASICO DE ALUMINIO Y MAGNESIO, DE FORMULA AL2MG6(OH)14(CO3)2.4 H2O, CONOCIDO COMUNMENTE COMO ALMAGATO Y LLEVAN COMO AGENTES CONSERVANTES ANTIMICROBIANOS A COMPUESTOS DE ESTRUCTURA BIGUANIDINICA, EN CANTIDADES DE ENTRE 0,005 Y 0,05 POR CIENTO, JUNTO CON EXCIPIENTES O DILUYENTES FARMACEUTICAMENTE ACEPTABLES. ESTAS FORMULACIONES SE USAN POR VIA ORAL PARA EL TRATAMIENTO DE TRASTORNOS DE TRACTO GASTROINTESTINAL, ESPECIALMENTE LA HIPERACIDEZ GASTRICA.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES9401999A ES2094093B1 (es) | 1994-09-22 | 1994-09-22 | Formulaciones farmaceuticas liquidas microbiologicamente estables para un carbonato basico de aluminio y magnesio. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES9401999A ES2094093B1 (es) | 1994-09-22 | 1994-09-22 | Formulaciones farmaceuticas liquidas microbiologicamente estables para un carbonato basico de aluminio y magnesio. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES2094093A1 ES2094093A1 (es) | 1997-01-01 |
| ES2094093B1 true ES2094093B1 (es) | 1997-08-01 |
Family
ID=8287515
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES9401999A Expired - Fee Related ES2094093B1 (es) | 1994-09-22 | 1994-09-22 | Formulaciones farmaceuticas liquidas microbiologicamente estables para un carbonato basico de aluminio y magnesio. |
Country Status (1)
| Country | Link |
|---|---|
| ES (1) | ES2094093B1 (es) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2153174B1 (es) * | 1971-09-23 | 1976-04-16 | Biotherax Lab | |
| GB2030042A (en) * | 1978-09-21 | 1980-04-02 | Beecham Group Ltd | Antacid fondant |
| FR2595249B1 (fr) * | 1986-03-10 | 1989-12-01 | Univ Victor Segalen Bordeaux 2 | Composition pharmaceutique consistant en une suspension de carbonate de calcium |
| DE3612086A1 (de) * | 1986-04-10 | 1987-10-15 | Bayer Ag | Konservierte antacida-zubereitungen |
-
1994
- 1994-09-22 ES ES9401999A patent/ES2094093B1/es not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2094093A1 (es) | 1997-01-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO1996020734A3 (en) | Oral gastrointestinal x-ray contrast agents in combination with pharmaceutically acceptable clays and surfactants | |
| CO4600739A1 (es) | Formulaciones liquidas orales a base de alendronato | |
| FR2673538B1 (fr) | Composition a base de 3-[2-(dimethylamino)ethyl]-n-methyl-1h-indole-5 methanesulfonamide pour l'administration buccale. | |
| DE60003160D1 (de) | Kombinationen von formoterol und mometasonfuroat | |
| ATE290015T1 (de) | Cyclosporinderivate, deren herstellung und pharmazeutische zubereitungen | |
| CA2123909A1 (en) | New combination of formoterol and budesonide | |
| CA2108455A1 (en) | Pharmaceutical compositions against gastric disorders | |
| CA2468771A1 (en) | Pharmaceutical composition for use in ophthalmology and rhinology | |
| NZ334124A (en) | Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease | |
| BR9500758A (pt) | Formulaçoes farmacêuticas para administraçao oral | |
| IL96995A0 (en) | Pharmaceutical compositions containing pimobendan and their preparation | |
| CA2377174A1 (en) | Oral administration forms for administering a fixed tramadol and diclofenac combination | |
| HU9302970D0 (en) | Swallowable prepartions for the treatment of pains of superior gastrointestinal tracts | |
| WO1992018111A3 (en) | Pharmaceutical composition for the treatment of gastritis | |
| CA2005980A1 (en) | Benzimidazole derivative with gastric acid inhibitory effect and process for its preparation | |
| AU8687391A (en) | Lithium treatment | |
| CA2152998A1 (en) | Anti-hyperglycemia pharmaceutical composition | |
| GR3024058T3 (en) | Pharmaceutical compositions containing 5-difluoromethoxy-2- (3,4-dimethoxy-2-pyridyl) methylsulfinyl] benzimidazole and an anti-helicobacter agent for the treatment of gastrointestinal disorders | |
| ES2094093B1 (es) | Formulaciones farmaceuticas liquidas microbiologicamente estables para un carbonato basico de aluminio y magnesio. | |
| SE0001916D0 (sv) | Novel formulation | |
| IT1306179B1 (it) | Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale. | |
| WO2004023979A3 (en) | Mucus formulation for mucosal surfaces and uses thereof | |
| HK1012242A1 (en) | Topical composition containing penciclovir | |
| CA2370501A1 (en) | Pharmaceutical composition for the therapy of lower urinary tract symptoms | |
| MXPA04002099A (es) | Composiciones medicinales para neuropatia diabetica. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EC2A | Search report published |
Date of ref document: 19970101 Kind code of ref document: A1 Effective date: 19970101 |
|
| PC2A | Transfer of patent | ||
| FD2A | Announcement of lapse in spain |
Effective date: 20180806 |